Cargando…

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205316/ https://www.ncbi.nlm.nih.gov/pubmed/35719214 http://dx.doi.org/10.2147/DDDT.S375987

Ejemplares similares

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
por: Walling, David P, et al.
Publicado: (2021)

Audit on prolactin monitoring for patients on oral risperidone, intramuscular risperidone, and intramuscular paliperidone
por: Bader, Mohamed
Publicado: (2021)

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2017)

Efficacy and safety of once-monthly Risperidone ISM(®) in schizophrenic patients with an acute exacerbation
por: Correll, Christoph U., et al.
Publicado: (2020)

Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
por: Álamo, Cecilio
Publicado: (2022)

An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder
por: Desousa, Avinash
Publicado: (2010)

Corrigendum to “Fluoxetine combined with risperidone in treatment of online gambling disorder-case report” [Heliyon 9 (3) (March 2023) Article e13772]
por: Bai, Mei, et al.
Publicado: (2023)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Corrigendum to: A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?
Publicado: (2023)

Early onset of treatment effects with oral risperidone
por: Raedler, Thomas J, et al.
Publicado: (2007)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Galactorrhea Induced by Risperidone
por: Sakaguchi, Shota, et al.
Publicado: (2019)

Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
por: Litman, Robert, et al.
Publicado: (2023)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

DELUSIONAL PARASITOSIS RESPONDING TO RISPERIDONE
por: Gowda, B.S.Narayana, et al.
Publicado: (2002)

Risperidone in the treatment of bipolar mania
por: Sajatovic, Martha, et al.
Publicado: (2006)

RISPERIDONE-INDUCED OCULOGYRIC CRISIS
por: Khalid, Abdul, et al.
Publicado: (2000)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

A Case of Priapism with Risperidone
por: Ginory, Almari, et al.
Publicado: (2014)

Development of Risperidone PLGA Microspheres
por: D'Souza, Susan, et al.
Publicado: (2014)

Comparative Pharmacology of Risperidone and Paliperidone
por: Corena-McLeod, Maria
Publicado: (2015)

Risperidone-induced skin rash
por: Janardhana, Priya, et al.
Publicado: (2016)

Spectrophotometric Estimation of Risperidone in Tablets
por: Jayanna, B. K., et al.
Publicado: (2014)

Risperidone-induced reversible neutropenia
por: Kattalai Kailasam, Vasanth, et al.
Publicado: (2017)

Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity [Corrigendum]
Publicado: (2023)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

COMPARATIVE EFFICACY OF CENTBUTINDOLE & RISPERIDONE IN SCHIZOPHRENIA
por: Chandra, R., et al.
Publicado: (2002)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Kumar, P.N. Suresh
Publicado: (1999)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Pandey, S.K.
Publicado: (1999)

Risperidone Associated Paralytic Ileus in Schizophrenia
por: Ramamourthy, Parthasarathy, et al.
Publicado: (2013)

Risperidone-induced Erythema Multiforme Minor
por: Pendharkar, Shreyas Shrikant, et al.
Publicado: (2017)

Risperidone and Levothyroxine for Managing “Myxedema Madness”
por: Patel, Rikinkumar S, et al.
Publicado: (2020)

Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study
por: Folquitto, Jefferson Cunha, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6f6cdnahd3vpq7qj6abj71rv7v